BLOOD LUTEINISING HORMONE DECREASED

This adverse event was reported 179 times

These drugs are most commonly taken by patients reporting BLOOD LUTEINISING HORMONE DECREASED:

# Drug Count
0 FINASTERIDE 19
1 TESTOSTERONE 17
2 FLUOXETINE HYDROCHLORIDE 8
3 GABAPENTIN 8
4 HYDROCORTISONE 8
5 LEVOTHYROXINE SODIUM 8
6 OMEPRAZOLE MAGNESIUM 8
7 SOMATROPIN 8
8 ANTI ITCH 7
9 ANTI-ITCH 7
See all common drugs associated with BLOOD LUTEINISING HORMONE DECREASED

BLOOD LUTEINISING HORMONE DECREASED is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TESTOSTERONE ENANTHATE 3 0.0018
1 TRIPTORELIN 6 0.0018
2 CETRORELIX ACETATE 1 0.0016
3 PEGVISOMANT 6 0.0015
4 TESTOSTERONE UNDECANOATE 2 0.0010
5 TAMOXIFEN CITRATE 5 0.0009
6 TESTOSTERONE 17 0.0007
7 CLOMIPHENE CITRATE 1 0.0007
8 MIFEPRISTONE 3 0.0006
9 VINBLASTINE SULFATE 1 0.0005
See all drugs enriched for association with BLOOD LUTEINISING HORMONE DECREASED

BLOOD LUTEINISING HORMONE DECREASED is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Progestin Antagonist [EPC] 3 0.0006
1 Androgen [EPC] 17 0.0006
2 Ergot Derivative [EPC] 2 0.0004
3 Calcitonin [EPC] 1 0.0003
4 CD52-directed Cytolytic Antibody [EPC] 4 0.0002
5 5-alpha Reductase Inhibitor [EPC] 21 0.0002
6 Somatostatin Analog [EPC] 1 0.0001
7 Provitamin D2 Compound [EPC] 3 0.0001
8 CTLA-4-directed Blocking Antibody [EPC] 4 0.0001
9 Nitrofuran Antibacterial [EPC] 1 0.0001
See all drug classes enriched for association with BLOOD LUTEINISING HORMONE DECREASED